Mutation of the RIIβ Subunit of Protein Kinase A Prevents Diet-Induced Insulin Resistance and Dyslipidemia in Mice

Diabetes

Volumn 50, Issue 7-12, 2001, Pages 2555-2562

  Schreyer, Sandra A ^a   Cummings, David E ^a   McKnight, G Stanley ^b   LeBoeuf, Renée C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; INSULIN; LIPID; REGULATORY SUBUNIT RIIBETA, CYCLIC AMP DEPENDENT PROTEIN KINASE; REGULATORY SUBUNIT RIIBETA, CYCLIC-AMP-DEPENDENT PROTEIN KINASE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; DIABETES MELLITUS; DIET; FEMALE; GENETICS; HISTOLOGY; HYPERLIPIDEMIA; INSULIN RESISTANCE; LONGITUDINAL STUDY; MALE; METABOLISM; MOUSE; MOUSE MUTANT; MUTATION; PHENOTYPE; PHYSIOLOGY; REFERENCE VALUE;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES MELLITUS; DIET; FEMALE; GLUCOSE; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; LIPIDS; LONGITUDINAL STUDIES; MALE; MICE; MICE, KNOCKOUT; MUTATION; PHENOTYPE; REFERENCE VALUES;

EID: 0035516189     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.11.2555     Document Type: Article

References (37)

1. Flegal KM, Carrol MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 22:39-47, 1998
2. Bosello O, Armellini F, Zamboni M, Fitchet M: The benefits of modest weight loss in type II diabetes. Int J Obes Relat Metab Disord 1:S10-S13, 1997
3. Jensen MD: Health consequences of fat distribution. Horm Res 48 (Suppl. 5):88-92, 1997
4. Edelman SV: Type II diabetes mellitus. Adv Intern Med 43:449-500, 1998
5. Garg A: Treatment of diabetic dyslipidemia. Am J Cardiol 81:47B-51B, 1998
6. Garber AJ: Vascular disease and lipids in diabetes. Med Clin North Am 82:931-948, 1998
7. Montague CT, O'Rahilly S: The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49:883-888, 2000
8. McKnight GS, Cummings DE, Amieux PS, Sikorski MA, Brandon EP, Planas JV, Motamed K, Idzerda RL: Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Prog Hormone Res 53:139-161, 1998
9. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS: Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A. Nature 382:622-626, 1996
10. Emorine L, Blin N, Strosberg AD: The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci 15:3-7, 1994
11. Meier MK, Alig L, Burgi-Saville ME, Muller M: Phenethanolamine derivatives with calorigenic and antidiabetic qualities. Int J Obes 8:215-225, 1984
12. Largis EE, Burns MG, Meunkel HA, Dolan JA, Claus TH: Antidiabetic and antiobesity effects of a highly selective β3-adrenoceptor agonist. Drug Dev Res 32:69-76, 1994
13. Himms-Hagen J, Cui J, Danforth E Jr, Tatjes DJ, Lang SS, Waters BL, Claus TH: Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol 266:R1371-R1382, 1994
14. Amieux PS, Cummings DE, Motamed K, Brandon EP, Wailes LA, Le K, Idzerda RL, McKnight GS: Compensatory regulation of RIα protein levels in protein kinase A mutant mice. J Biol Chem 272:3993-3998, 1997
15. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN: Diet induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1170, 1988
16. Surwit RS, Seldin MF, Kuhn CM, Cochrane C, Feinglos MN: Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetes C57BL/6J mice. Diabetes 40:82-87, 1991
17. Harte RA, Kirk EA, Rosenfeld ME, LeBoeuf RC: The initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice. Horm Metab Res 31:570-575, 1999
18. Schreyer SA, Wilson DL, LeBoeuf RC: C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136:17-24, 1998
19. LeBouef RC, Caldwell M, Kirk E: Regulation by nutritional status of lipids and apolipoproteins A-I, A-II, and A-IV in inbred mice. J Lipid Res 35:121-133, 1994
20. Lusis AJ, Taylor BA, Quon D, Zollman S, LeBoeuf R: Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J Biol Chem 262:7594-7604, 1987
21. Leiter EH, Le PH, Coleman DL: Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits. Immunogenetics 26:6-13, 1987
22. Schreyer SA, Chua SC Jr, LeBoeuf RC: Obesity and diabetes in TNF-alpha receptor-deficient mice. J Clin Invest 102:402-411, 1998
23. Camus MC, Chapman MJ, Forgez P, Laplaud PM: Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus. J Lipid Res 24:1210-1228, 1983
24. Weisgraber KH, Mahley RW: Characterization of apolipoprotein E-containing lipoproteins. Methods Enzymol 129:145-166, 1986
25. Brandon EP, Idzerda RL, McKnight GS: PKA isoforms, neural pathways, and behaviour: making the connection. Curr Opin Neurobiol 7:397-403, 1997
26. Brandon EP, Logue SF, Adams MR, Qi M, Sullivan SP, Matsumoto AM, Dorsa DM, Wehner JM, McKnight GS: Defective motor behaviour and neural gene expression in RIIβ-protein kinase A mutant mice. J Neurosci 18:3639-3649, 1998
27. Adams MR, Brandon EP, Chartoff JH, Idzerda RL, Dorsa DM, McKnight GS: Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. Proc Natl Acad Sci U S A 94:12157-12161, 1998
28. Planas JV, Cummings DE, Idzerda RL, McKnight GS: Mutation of the RIIβ subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue. J Biol Chem 274:36281-36287, 1999
29. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight reduction in ob/ob mice. Science 269:540-543, 1995
30. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
31. Inui A: Feeding and body-weight regulation by hypothalamic neuropeptide-mediation of the actions of leptin. Trends Neurosci 22:62-67, 1999
32. Sevetson BR, Kong X, Lawrence JC Jr: Increasing cAMP attenuates activation of mitogen activated protein kinase. Proc Natl Acad Sci U S A 90:10305-10309, 1993
33. Kirk EA, Moe GL, Caldwell MT, Lernmark JA, Wilson DL, LeBoeuf RC: Hyper- and hypo-responsiveness to dietary fat and cholesterol among inbred mice: searching for level and variability genes. J Lipid Res 36:1522-1532, 1995
34. Srivastava RA, Jiao S, Tang JJ, Pfleger BA, Kitchens RT, Schonfeld G: In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice. Biochim Biophys Acta 1086:29-43, 1991
35. Ishida BY, Blanche PJ, Nichols AV, Yashar M, Paigen B: Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. J Lipid Res 32:559-568, 1991
36. LeBoeuf RC, Tsao W, Kirk E, Childs MT: Cholesterol feeding induced cholesterol-rich VLDL in atherosclerosis-susceptible mice regardless of dietary fat content. Nutrition Res 13:549-561, 1993
37. Leiter EH, Chapman HD, Coleman DL: The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. J Lipid Res 36:1522-1532, 1989